SPY391.36-0.50 -0.13%
DIA313.41-2.14 -0.68%
IXIC11,499.69+81.54 0.71%

--HC Wainwright Adjusts Enlivex Therapeutics' Price Target to $15 from $33, Keeps Buy Rating

MT Newswires · 05/02/2022 04:24

Please log in to view news